• UCL Twitter account
  • UCL YouTube channel
  • UCL Facebook page
  • UCL SoundCloud channel
  • UCL iTunes store

Information for Staff


Select dates to view past and future events

13:00 - 14:00 21 September 2017

QSMS Centre Departmental Seminar: "Disease modification in multiple sclerosis has just become simpler”


Gilliatt Lecture Theatre | Institute of Neurology (link Map)
Queen Square House | Queen Square | London | WC1N 3BG | United Kingdom

Open to: Academic | Student

Speaker: Dr Klaus Schmierer, Reader in Clinical Neurology & Consultant Neurologist, The Blizard Institute, Queen Mary University of London & The Royal London Hospital, Barts Health NHS Trust

Abstract: The common initial presentation of multiple sclerosis (MS) as a relapsing and remitting disease betrays the loss from onset of reserve capacity. Disease modifying treatment (DMT) as early as possible is therefore a valuable proposition, however which of the growing number of DMT options should be used? Whilst inspection of post mortem samples and its in vivo proxy MRI inform on outcome, recent clinical trials not only raised DMT options to new heights (and lows). They also facilitated a new understanding of MS immunology, the focus of DMT, and assessment of treatment response. Against this backdrop I will propose a shift in DMT that may both improve and simplify the management of people with MS.


Tina Holmes
Please email | t.holmes@ucl.ac.uk